ARS Pharmaceuticals, Inc. - SPRY
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 16
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| 4 | 7 |
| SCHEDULE 13G/A | 3 |
| 8-K | 3 |
| SCHEDULE 13G | 3 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | — | 0001104659-26-062527 | View |
| May 15, 2026 | 8-K | May 15, 2026 | 0001193125-26-225055 | View |
| May 13, 2026 | 8-K | May 12, 2026 | 0001193125-26-220671 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | — | 0002012383-26-001716 | View |
| Mar 31, 2026 | SCHEDULE 13G/A | — | 0001104659-26-037977 | View |
| Mar 24, 2026 | SCHEDULE 13G | — | 0001104659-26-033875 | View |
| Mar 09, 2026 | 8-K | Mar 09, 2026 | 0001193125-26-097467 | View |
| Feb 13, 2026 | SCHEDULE 13G | — | 0001104659-26-015245 | View |
| Jan 21, 2026 | SCHEDULE 13G | — | 0002012383-26-000722 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001378550-26-000003 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001951291-26-000002 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001951238-26-000003 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001380762-26-000002 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001398595-26-000002 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001951287-26-000002 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001794284-26-000002 | View |